secwatch.observer — SEC 8-K summary
======================================

Issuer:     Valion Bio, Inc. (VBIO)
CIK:        0001787740
Form:       8-K
Filed at:   2023-02-13T23:59:59+00:00
Accession:  0000950170-23-002621
Event type: other_material
Sentiment:  neutral
Materiality: 0.70
Item codes: 1.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Tivic Health closes $5M public offering of 20M shares at $0.25 each
-------------------------------------------------------------------

- Priced offering of 20M shares at $0.25 each for $5M gross; net proceeds ~$4.1M after underwriting discounts and expenses.
- Underwriters have 45-day over-allotment option to buy up to 3M additional shares at $0.25 less discount.
- Issued 1M share Representative's Warrants at $0.3125 per share, exercisable 180 days after offering for 4 years.
- Proceeds to be used for ClearUp sales expansion, healthcare professional network penetration, and clinical/regulatory costs for new product candidates.
- Lock-up agreements for 3 months on executive officers, directors, and certain shareholders.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1787740/000095017023002621/0000950170-23-002621-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1787740/000095017023002621/tivc-20230208.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-002621

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer